JNJ Short Volume
Johnson & Johnson (JNJ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $554.67B, listed on NYSE, employing roughly 138,100 people, carrying a beta of 0.26 to the broader market. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. Led by Joaquin Duato, public since 1943-01-02.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 996.1K
- Total Volume
- 2.1M
- Short %
- 48.47%
- 30-Day Avg Short %
- 40.96%
Showing 30 days of FINRA short volume data for Johnson & Johnson.
Learn how short volume is reported and how to read the data →
Frequently asked JNJ short volume questions
- What is the daily JNJ short volume?
- As of May 15, 2026, Johnson & Johnson (JNJ) short volume is 996.1K shares against 2.1M total reported volume, or 48.47% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is JNJ short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does JNJ short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.